在2型糖尿病中,蒂尔泽帕提德与类似葡萄糖类-1受体激动剂的眼睛结果
Alexander T Hong1, Forest Lin2, Jeremy D Keenan3
1Keck School of Medicine of University of Southern California, Los Angeles, CA.
Ophthalmology. Retina
|February 8, 2026
概括
蒂尔泽帕提德是一种双GIP/GLP-1RA,在2型糖尿病患者中,与非GIP GLP-1RA相比,视网膜并发症的风险较低. 这表明tirezepatide具有有利的眼部安全概况,需要进一步调查.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 类似葡萄糖-1受体激动剂 (GLP-1RAs) 已经证明了各种各样的眼睛效应.
- 蒂尔泽帕提德是一种双重依赖葡萄糖的胰岛素型多 (GIP) /GLP-1RA,提供了增强的心脏代谢益处,但其眼部安全性尚未得到充分证实.
研究的目的:
- 为了比较2型糖尿病 (T2D) 患者与非GIPGLP-1RAs治疗tirezepatide的视网膜并发症的发生率.
主要方法:
- 一项回顾性队列研究利用了从2022年6月到2025年6月的全国电子健康记录网络.
- 纳入了T2D发病的成年人,他们使用了tirzepatide或非GIP的GLP-1RA,但不包括使用其他二线疗法的人.
- 倾向性得分匹配 (1:1) 用于比较结果,包括糖尿病视网膜病变 (DR),糖尿病黄斑胀 (DME),玻璃体出血/视网膜脱落 (VH/RD),视力挽救干预措施和非动脉炎前面缺血视神经病变 (NAION) 在36个月内.
主要成果:
- 与非GIP GLP-1RAs相比,提尔泽帕提德的使用与DR (HR 0.60),DME (HR 0.63),VH/RD (HR 0.36),DR相关的视力挽救干预 (HR 0.44) 和NAION (HR 0.31) 的风险降低有关.
- 这些关联在各个子组中保持一致,包括甲福明或胰岛素使用者以及开始额外抗高血糖治疗的人.
结论:
- 在T2D患者中,与缺乏GIP活性的GLP-1RA相比,蒂尔泽帕提德表明视网膜并发症,视力挽救干预和NAION的风险较低.
- 这些发现表明,泽帕提德对眼睛的安全性是有利的.
- 建议进行前性研究以确认.
相关概念视频
Glucagon-like Receptor Agonists
995
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
995
Diabetes Mellitus: Type 2 and Gestational
5.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
Types of Receptors: Internal Receptors
32.7K
Many cellular signals are hydrophilic and cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind intracellular receptors that reside within the cell cytoplasm or nucleus. Many mammalian steroid hormones and nitric oxide (NO) gas use this cell signaling mechanism.
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
32.7K
Predicting Products: SN1 vs. SN2
17.4K
Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
With increased substitution on the alkyl halide,...
17.4K
Types of Receptors: Cell Surface Receptors
27.5K
Cell-surface receptors, also known as transmembrane receptors, are cell surface, membrane-anchored (integral) proteins that bind to external ligand molecules. This type of receptor spans the plasma membrane and performs signal transduction, converting an extracellular signal into an intracellular signal. Ligands that interact with cell-surface receptors do not have to enter the cell that they affect. Cell-surface receptors are also called cell-specific proteins or markers because they are...
27.5K


